| Author (Corporate) | European Court of Justice, Information Service |
|---|---|
| Publisher | European Court of Justice (ECJ) |
| Series Details | T-677/14 |
| Publication Date | 2014 |
| Content Type | Overview |
|
Summary: The General Court annuls in part the European Commission’s decision finding the existence of restrictive agreements and an abuse of a dominant position on the market for perindopril, a medicine used to treat hypertension and heart failure. The General Court confirms, however, that certain patent settlement agreements may be restrictive of competition by object. |
|
| Source Link | Link to Main Source http://curia.europa.eu/juris/documents.jsf?num=T-677/14 |
| Related Links |
|
| Subject Categories | Business and Industry |
| Subject Tags | Medicines | Medical Devices |
| Keywords | CJEU Judgments, Competition Law |
| Countries / Regions | Europe |
| International Organisations | European Union [EU] |
